8,082 Shares in MetLife, Inc. (NYSE:MET) Purchased by Quantessence Capital LLC

Quantessence Capital LLC purchased a new stake in MetLife, Inc. (NYSE:MET - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 8,082 shares of the financial services provider's stock, valued at approximately $662,000.

A number of other large investors have also modified their holdings of MET. Anchor Investment Management LLC lifted its holdings in MetLife by 12.5% in the third quarter. Anchor Investment Management LLC now owns 6,115 shares of the financial services provider's stock valued at $504,000 after acquiring an additional 681 shares during the period. World Investment Advisors LLC acquired a new stake in MetLife during the third quarter valued at $336,000. Wilmington Savings Fund Society FSB acquired a new position in shares of MetLife in the third quarter worth about $701,000. Tidal Investments LLC grew its position in shares of MetLife by 3.9% during the 3rd quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider's stock valued at $1,590,000 after acquiring an additional 718 shares during the period. Finally, Synovus Financial Corp boosted its position in MetLife by 5.5% during the third quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider's stock worth $1,874,000 after purchasing an additional 1,183 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on MET shares. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Wells Fargo & Company lowered their price objective on MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. JPMorgan Chase & Co. dropped their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a research report on Wednesday, April 2nd. BMO Capital Markets started coverage on shares of MetLife in a report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price for the company. Finally, Cowen restated a "buy" rating on shares of MetLife in a research report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $92.46.

MetLife Stock Performance

NYSE:MET opened at $70.38 on Tuesday. The company has a market cap of $47.94 billion, a price-to-earnings ratio of 11.79, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. The company has a fifty day simple moving average of $78.94 and a two-hundred day simple moving average of $82.04. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.